Search

We asked the field’s greatest minds: “What improvements do we need to see in cell and gene supply chains?”

Novasep, Sartorius has solutions to assist with emerging modalities, such as mRNA, pDNA and AAV, as well as mAbs and traditional vaccines. At the company’s annual general shareholders’ meeting in March 2022,

Supply chain lessons have been learned since COVID-19, so why are we seeing so many drug shortages?

We spoke to Prateek Gadhoke, Global Head of Specialty Care Procurement at Sanofi, to ask what makes a strong supply chain.

How is AI helping to combat infectious diseases?

The use of multimodal chromatography is increasing in biopharma purification processes. Here’s why.

From chasing drug lords to advising US presidents, it’s fair to say Robert Pinco has enjoyed a varied career.

Here’s why virus-like particles could open a new chapter in combating disease.

The Medicine Maker’s round up of the top news stories in the pharma industry in March.

Experts from Axolabs GmbH and Bruker Daltonics explain the benefits behind mass spectrometry for oligonucleotides in drug discovery